Latest news with #Levetiracetam
The Hindu
12-07-2025
- The Hindu
Pharma distributor in Karimnagar arrested in counterfeit anti-epileptic drug case, second in a week
The Telangana Drugs Control Administration (DCA) on Friday, July 11 arrested R. Venu Gopal, Managing Partner and Competent Person of Venu Medical Agencies in Karimnagar, for selling counterfeit anti-epileptic tablets falsely labelled as a product of a leading pharmaceutical company. This is the second arrest by the DCA in a week in connection with the distribution of counterfeit Levipil 500 tablets (Levetiracetam 500 mg), a drug prescribed to treat epilepsy. Earlier this week, Manish Kumar, Partner-cum-Competent Person of Arvind Pharma Distributors in Gandhinagar, Hyderabad, was arrested for a similar offence. The latest arrest follows a raid conducted on July 5 at Venu Medical Agencies, located in Sai Nagar, Doctors Street, Karimnagar, where officials seized a consignment of counterfeit Levipil 500 tablets. The packaging falsely claimed the drug was manufactured by Sun Pharma Laboratories Limited. A batch comparison conducted by Sun Pharma confirmed that the seized tablets were counterfeit. Following this, Venu Gopal was arrested and produced before the Additional Judicial First Class Magistrate Court in Karimnagar, which remanded him to judicial custody until July 23. He is currently lodged at the District Prison in Karimnagar.
Hans India
07-07-2025
- Hans India
DCA seizes fake Levipil 500 tablets
Hyderabad: The Telangana State Drugs Control Administration (DCA) raided multiple places based on the information found fake Levipil 500 tablets (Levetiracetam 500 mg) tablets and seized counterfeit 'Levipil 500'. These were falsely claimed to be made by Sun Pharma Laboratories Ltd. According to DCA, these counterfeits were being sold in Kavadiguda in Hyderabad, and Karimnagar. During the raids, the police seized counterfeit drugs from two places – first at Arvind Pharma Distributors in BI Colony, Kavadiguda in Hyderabad and another at Venu Medical Agencies in Sai Nagar, Doctors Street in Karimnagar district. In a raid, the special teams from the DCA found fake stocks of Levipil 500 Tablets. The Levipil 500 Tablet is an anti-epileptic medicine used to treat fits in epilepsy. A comparison statement for the suspected batches was obtained from the original manufacturer, Sun Pharma Laboratories Ltd., against the corresponding genuine batch. The manufacturer confirmed that the batch of 'Levipil 500' Tablets (Levetiracetam Tablets 500 mg) detected by the Drugs Control Administration was indeed Counterfeit Drugs. A senior officer at DCA said that the teams raided Arvind Pharma Distributors, SBI Colony, Kavadigudaon on 4th July, and the raid conducted on 5th July 2025 at Venu Medical Agencies, located in Sai Nagar, Doctors Street, Karimnagar, a counterfeit version of 'Levipil 500' Tablets (Levetiracetam Tablets 500 mg), falsely claimed to be manufactured by Sun Pharma Laboratories Limited, was detected. Counterfeit drugs were seized during both raids. Further investigation will be conducted, and appropriate action will be taken against all offenders involved. The DCA urges the public to report any suspected drug manufacturing activities. This includes narcotics and psychotropic substances in residential, commercial, or industrial areas. Citizens can also report any illegal activities related to medicines. Call the Drugs Control Administration, Telangana, at their Toll-Free Number 1800-599-6969. They are available from 10:30 am to 5 pm on all working days.
The Hindu
06-07-2025
- The Hindu
Counterfeit anti-epilepsy drugs seized in Hyderabad and Karimnagar
The Telangana Drugs Control Administration (DCA) has seized counterfeit anti-epilepsy medicines from pharmacies in Hyderabad and Karimnagar. During surprise inspections carried out on July 4, DCA officials raided Anand Pharma Distributors in Kavadiguda, and Venu Medical Agencies on Doctors Street, Karimnagar. The teams detected fake stocks of Levipil 500 tablets, used in the treatment of epilepsy, being sold to unsuspecting customers. Following the seizures, the DCA obtained a comparison statement from the original manufacturer, Sun Pharma Laboratories Limited., for the suspected batches. The pharmaceutical company confirmed that the seized Levipil 500 tablets (Levetiracetam Tablets 500 mg) were indeed counterfeit.
&w=3840&q=100)
Business Standard
22-04-2025
- Health
- Business Standard
Dr Reddy's, Lupin recall products in US due to manufacturing errors: USFDA
Dr Reddy's Laboratories and Lupin are recalling products in the US market due to labelling and manufacturing errors, respectively, according to the US health regulator. As per its latest Enforcement Report, US Food and Drug Administration (USFDA) said a US-based subsidiary of the Hyderabad-based drug major is recalling certain batches of a generic antiepileptic drug in the US market. Princeton-based Dr Reddy's Laboratories, Inc is recalling 4,010 bags of Levetiracetam 0.75 pc in Sodium Chloride Injection (1,000 mg/100 mL) in the US due to labelling mix up, USFDA said. "The infusion bag is incorrectly labelled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL," it added. The company has issued the Class 1 nationwide (US) recall on March 13 this year, the US health regulator noted. As per the USFDA, a Class I recall pertains to defective products that can cause serious health problems. In a separate filing, the US health regulator said that a US-based subsidiary of Mumbai-headquartered Lupin is recalling an antidepressant medication which used in the treatment of obsessive-compulsive disorder. Naples-based Lupin Pharmaceuticals Inc is recalling 2,724 bottles of clomiPRAMINE hydrochloride Capsules USP, 25 mg, due to "Failed Impurities/Degradation Specifications", USFDA said. The company initiated the Class II recall on April 18, it added.
Time of India
22-04-2025
- Health
- Time of India
Dr Reddy's, Lupin recall products in US due to labelling, manufacturing errors: USFDA
Dr Reddy's Laboratories and Lupin are recalling products in the US market due to labelling and manufacturing errors, respectively, according to the US health regulator. As per its latest Enforcement Report, US Food and Drug Administration (USFDA) said a US-based subsidiary of the Hyderabad-based drug major is recalling certain batches of a generic antiepileptic drug in the US market. Princeton-based Dr Reddy's Laboratories, Inc is recalling 4,010 bags of Levetiracetam 0.75 pc in Sodium Chloride Injection (1,000 mg/100 mL) in the US due to labelling mix up, USFDA said. "The infusion bag is incorrectly labelled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL," it added. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Join new Free to Play WWII MMO War Thunder War Thunder Play Now Undo The company has issued the Class 1 nationwide (US) recall on March 13 this year, the US health regulator noted. As per the USFDA, a Class I recall pertains to defective products that can cause serious health problems. Live Events In a separate filing, the US health regulator said that a US-based subsidiary of Mumbai-headquartered Lupin is recalling an antidepressant medication which used in the treatment of obsessive-compulsive disorder. Naples-based Lupin Pharmaceuticals Inc is recalling 2,724 bottles of clomiPRAMINE hydrochloride Capsules USP, 25 mg, due to "Failed Impurities/Degradation Specifications", USFDA said. The company initiated the Class II recall on April 18, it added.
